TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma.
Schaettler MO, Desai R, Wang AZ, Livingstone AJ, Kobayashi DK, Coxon AT, Bowman-Kirigin JA, Liu CJ, Li M, Bender DE, White MJ, Kranz DM, Johanns TM, Dunn GP.
Schaettler MO, et al. Among authors: coxon at.
J Immunother Cancer. 2023 Feb;11(2):e006121. doi: 10.1136/jitc-2022-006121.
J Immunother Cancer. 2023.
PMID: 36808076
Free PMC article.